Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2006-10-06

Clinical Trial Update: Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on intraperitoneal hyperthermic chemotherapy for epithelial ovarian cancer (FIGO stage IIIC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Epithelial Ovarian Carcinoma, Figo Stage IIIC | Phase 2 | Status: UNKNOWN